Cardiac Arrhythmias and Covid-19

Detalhes bibliográficos
Autor(a) principal: Fagundes,Alexsandro Alves
Data de Publicação: 2021
Outros Autores: Melo,Sissy Lara de, Armaganijan,Luciana, Kuniyoshi,Ricardo, Moraes,Luis Gustavo Belo de, Borges,Vanessa Alves Guimarães, Scanavacca,Mauricio, Martinelli Filho,Martino, Teixeira,Ricardo Alkmim
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Journal of Cardiovascular Sciences (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201
Resumo: Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain.
id SBC-2_a5313195719e8cb78de1979ec75066b9
oai_identifier_str oai:scielo:S2359-56472021005012201
network_acronym_str SBC-2
network_name_str International Journal of Cardiovascular Sciences (Online)
repository_id_str
spelling Cardiac Arrhythmias and Covid-19Coronavirus InfectionsCardiac ArrhythmiasArtificial PacemakerAbstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain.Sociedade Brasileira de Cardiologia2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201International Journal of Cardiovascular Sciences n.ahead 2021reponame:International Journal of Cardiovascular Sciences (Online)instname:Sociedade Brasileira de Cardiologia (SBC)instacron:SBC10.36660/ijcs.20200123info:eu-repo/semantics/openAccessFagundes,Alexsandro AlvesMelo,Sissy Lara deArmaganijan,LucianaKuniyoshi,RicardoMoraes,Luis Gustavo Belo deBorges,Vanessa Alves GuimarãesScanavacca,MauricioMartinelli Filho,MartinoTeixeira,Ricardo Alkmimeng2021-09-01T00:00:00Zoai:scielo:S2359-56472021005012201Revistahttp://publicacoes.cardiol.br/portal/ijcshttps://old.scielo.br/oai/scielo-oai.phptailanerodrigues@cardiol.br||revistaijcs@cardiol.br2359-56472359-4802opendoar:2021-09-01T00:00International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC)false
dc.title.none.fl_str_mv Cardiac Arrhythmias and Covid-19
title Cardiac Arrhythmias and Covid-19
spellingShingle Cardiac Arrhythmias and Covid-19
Fagundes,Alexsandro Alves
Coronavirus Infections
Cardiac Arrhythmias
Artificial Pacemaker
title_short Cardiac Arrhythmias and Covid-19
title_full Cardiac Arrhythmias and Covid-19
title_fullStr Cardiac Arrhythmias and Covid-19
title_full_unstemmed Cardiac Arrhythmias and Covid-19
title_sort Cardiac Arrhythmias and Covid-19
author Fagundes,Alexsandro Alves
author_facet Fagundes,Alexsandro Alves
Melo,Sissy Lara de
Armaganijan,Luciana
Kuniyoshi,Ricardo
Moraes,Luis Gustavo Belo de
Borges,Vanessa Alves Guimarães
Scanavacca,Mauricio
Martinelli Filho,Martino
Teixeira,Ricardo Alkmim
author_role author
author2 Melo,Sissy Lara de
Armaganijan,Luciana
Kuniyoshi,Ricardo
Moraes,Luis Gustavo Belo de
Borges,Vanessa Alves Guimarães
Scanavacca,Mauricio
Martinelli Filho,Martino
Teixeira,Ricardo Alkmim
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Fagundes,Alexsandro Alves
Melo,Sissy Lara de
Armaganijan,Luciana
Kuniyoshi,Ricardo
Moraes,Luis Gustavo Belo de
Borges,Vanessa Alves Guimarães
Scanavacca,Mauricio
Martinelli Filho,Martino
Teixeira,Ricardo Alkmim
dc.subject.por.fl_str_mv Coronavirus Infections
Cardiac Arrhythmias
Artificial Pacemaker
topic Coronavirus Infections
Cardiac Arrhythmias
Artificial Pacemaker
description Abstract Cardiovascular manifestations of COVID-19 include cardiac rhythm disturbances, whose mechanisms, incidence, and most common types are not well established in this population. Intense inflammatory response and metabolic activity contribute to recurrence of pre-existing arrhythmias, and other arrhythmias can occur due to myocardial injury, acute coronary insufficiency, and electrolyte disturbances. Brady- and tachyarrhythmias, as well as conduction disorders have been described. QT interval prolongation and fatal ventricular arrhythmias ( Torsades de Pointes ) may result from the pathological process or adverse effect of drugs (antiarrhythmics, chloroquine / hydroxychloroquine, azithromycin and antivirals). Patients with congenital heart disease and hemodynamic repercussions, patients with signs of heart failure, pulmonary hypertension, cyanosis, hypoxemia, and those who underwent heart transplantation and immunosuppression are at greater risk. In patients with implantable cardioverter-defibrillators (ICDs), the risk depends on the presence of structural heart disease. In the course of COVID-19, in-person assessment of these patients should be limited to high-risk situations, including syncope, worsening of heart failure and shock delivery by ICDs. Likewise, cardiac implantable electronic device implantation or replacement surgery should be limited to emergency and urgent cases, including symptomatic high-degree atrioventricular block, ICD for secondary prevention and pulse generator replacement due to battery drain.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472021005012201
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.36660/ijcs.20200123
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cardiologia
publisher.none.fl_str_mv Sociedade Brasileira de Cardiologia
dc.source.none.fl_str_mv International Journal of Cardiovascular Sciences n.ahead 2021
reponame:International Journal of Cardiovascular Sciences (Online)
instname:Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
instname_str Sociedade Brasileira de Cardiologia (SBC)
instacron_str SBC
institution SBC
reponame_str International Journal of Cardiovascular Sciences (Online)
collection International Journal of Cardiovascular Sciences (Online)
repository.name.fl_str_mv International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC)
repository.mail.fl_str_mv tailanerodrigues@cardiol.br||revistaijcs@cardiol.br
_version_ 1754732627440435200